Answer to Question 1
ANS: C
Glargine insulin is indicated for once daily subcutaneous administration to treat adults and children with type 1 diabetes and adults with type 2 diabetes. According to the package labeling, the once daily injection should be given at bedtime.
Glargine insulin should not be given more than once a day, therefore the other answer options are not correct.
Answer to Question 2
ANS: A
NPH insulin is the only insulin suitable for mixing with short-acting insulins, such as insulin aspart (NovoLog).
These insulins are compatible and are mixed frequently for management of diabetics.
The overall potency of each insulin is not increased by mixing them together.
Ultralente is not used any longer in the United States.